Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) injection does not need to be taken on an empty stomach. Unlike the oral Wegovy tablet, the once-weekly subcutaneous injection can be given at any time of day, with or without food, on any day of the week — your meal schedule does not affect how the medicine is absorbed. That said, many people find that injecting at roughly the same time each week makes the routine easier to stick to, and some find that injecting after eating slightly eases any initial nausea. These are prescription-only medicines, and a prescriber is always the right person to guide your specific routine. If you are asking about the Wegovy treatment itself more broadly, the sections below go into the detail behind this question and a few closely related ones our prescribers are regularly asked.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
No. The Patient Information Leaflet for the Wegovy subcutaneous pen is clear on this point: injectable semaglutide can be given at any time of day, regardless of meals. This is because the medicine is delivered directly into the tissue beneath the skin, your stomach contents have no meaningful bearing on how quickly or completely it reaches your bloodstream. So if you tend to inject on a Saturday morning after breakfast, or on a Wednesday evening before dinner, neither choice puts you at a clinical disadvantage.
This often surprises people, because the empty-stomach rule is very prominent for the Wegovy tablet. The confusion is understandable. The two formulations work differently in the body, and the fasting requirement for the tablet is entirely about how the absorption enhancer (SNAC) works in the gut lining, irrelevant for the injected version. You can read more about how the two forms compare on our page about semaglutide.
What does matter for the injection is consistency of the day. Keeping to roughly the same day each week maintains steadier drug levels. If you need to shift your injection day occasionally, most prescribers are relaxed about a short shift, provided doses are at least four days apart, but confirm any change with your own clinical team rather than guessing.
Yes, completely. A question our prescribers hear most weeks is whether the empty-stomach rule applies to the injection too, and the honest answer is that it only applies to the oral tablet. The 25 mg Wegovy tablet was approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management. Its dosing instructions are strict by design.
The tablet must be taken first thing in the morning, before any food, coffee, juice or other medicines. You swallow it whole with a small amount of plain water (up to around 120 ml) and then wait at least 30 minutes before eating or drinking anything else. The reason is pharmacological: the absorption enhancer that carries semaglutide across the stomach lining works best in a fasting, low-acid environment. Fatty food or coffee before the tablet significantly reduces how much semaglutide reaches your system.
One practical upside: unlike the injection, the tablet needs no refrigeration. Room-temperature storage makes it genuinely travel-friendly. If you are weighing up the two forms, the question of timing and lifestyle fit is worth thinking through before you start.
Nausea is the most commonly reported side effect when starting Wegovy or stepping up a dose, and it tends to be most noticeable in the first few days after each injection. The relationship between food and injection-related nausea is not about absorption, it is about comfort.
Some people find that injecting shortly after a light, low-fat meal reduces the intensity of nausea in those first days. Others find injecting in the evening means any queasiness passes during sleep. Neither approach is clinically superior; both are practical strategies that patients and prescribers work out together. Rich, fatty or spicy meals in the hours around an injection can make nausea worse, so keeping things plain around injection time is sensible early on.
Nausea generally improves as the body adjusts, typically within a couple of weeks of a new dose. If it is severe, persistent, or accompanied by vomiting that makes it hard to keep fluids down, contact your clinical team rather than waiting it out. The Wegovy FAQs cover other common early experiences if you want broader context.
If you are thinking about the cost of starting treatment, understanding UK Wegovy pricing is a reasonable next step before committing.
In practice, both. The prescriber sets the dose and the escalation schedule. You choose the day and time that fits your life, within the guidance above. This is one of the genuinely flexible aspects of Wegovy, unlike some medicines that must be taken at a fixed hour, the injection's only structural constraint is the once-weekly interval.
The NHS patient-level guidance on semaglutide covers what to do if you miss a dose, which is a common follow-on question: if the missed injection was five or more days ago, skip it and return to your normal schedule rather than doubling up. Do not adjust doses or timing based on how you feel from week to week without speaking to your prescriber first, titration decisions rest with the clinical team, not self-management.
At nume, every repeat order goes through a fresh clinical review before dispatch. Our prescribers take the time to check how you are getting on, not just to reissue the prescription. If you have questions about what to expect at each stage, our clinical team explains the oversight behind every prescription we issue. When you are ready to start, begin your free consultation and a GPhC-registered prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.